André Happe

771 total citations
34 papers, 516 citations indexed

About

André Happe is a scholar working on Molecular Biology, Artificial Intelligence and Pulmonary and Respiratory Medicine. According to data from OpenAlex, André Happe has authored 34 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Artificial Intelligence and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in André Happe's work include Biomedical Text Mining and Ontologies (7 papers), Data Quality and Management (4 papers) and Prostate Cancer Treatment and Research (4 papers). André Happe is often cited by papers focused on Biomedical Text Mining and Ontologies (7 papers), Data Quality and Management (4 papers) and Prostate Cancer Treatment and Research (4 papers). André Happe collaborates with scholars based in France, Germany and United Kingdom. André Happe's co-authors include Emmanuel Oger, Emmanuel Nowak, Sandrine Kerbrat, Frédéric Balusson, A. Dupuy, C. Droitcourt, Lucie‐Marie Scailteux, Erwan Drézen, Daniel Chourrout and Edwige Quillet and has published in prestigious journals such as PEDIATRICS, American Journal of Epidemiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

André Happe

30 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
André Happe France 14 95 74 71 63 60 34 516
Levent Doğanay Türkiye 17 40 0.4× 171 2.3× 77 1.1× 70 1.1× 26 0.4× 62 950
Rui Yang China 17 64 0.7× 103 1.4× 37 0.5× 178 2.8× 10 0.2× 88 1.0k
Libing Ma China 16 171 1.8× 152 2.1× 26 0.4× 151 2.4× 7 0.1× 65 670
Ulrich Buergi Switzerland 12 30 0.3× 228 3.1× 36 0.5× 60 1.0× 4 0.1× 17 585
Li‐Wen Huang China 13 70 0.7× 120 1.6× 17 0.2× 38 0.6× 8 0.1× 33 509
Zhu Ming China 12 102 1.1× 130 1.8× 37 0.5× 37 0.6× 2 0.0× 25 581
Xiaoming Su China 12 106 1.1× 280 3.8× 18 0.3× 23 0.4× 6 0.1× 47 748

Countries citing papers authored by André Happe

Since Specialization
Citations

This map shows the geographic impact of André Happe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Happe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Happe more than expected).

Fields of papers citing papers by André Happe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Happe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Happe. The network helps show where André Happe may publish in the future.

Co-authorship network of co-authors of André Happe

This figure shows the co-authorship network connecting the top 25 collaborators of André Happe. A scholar is included among the top collaborators of André Happe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Happe. André Happe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Maruani, A., S. Barbarot, C. Abasq, et al.. (2023). Factors associated with early relapse of infantile haemangioma in children treated for at least six months with oral propranolol: A case-control study using the 2014–2021 French Ouest DataHub. Annales de Dermatologie et de Vénéréologie. 150(3). 189–194. 3 indexed citations
3.
Garès, Valérie, Li‐Chun Zhang, André Happe, et al.. (2023). Cox regression with linked data. Statistics in Medicine. 43(2). 296–314.
4.
Gal, Solène Le, C. Gautier, André Happe, et al.. (2022). Apparent Absence of Selective Pressure on Pneumocystis jirovecii Organisms in Patients with Prior Methotrexate Exposure. Antimicrobial Agents and Chemotherapy. 66(12). e0099022–e0099022. 1 indexed citations
5.
Chauvet, Guillaume, et al.. (2022). Extending the Fellegi-Sunter record linkage model for mixed-type data with application to the French national health data system. Computational Statistics & Data Analysis. 179. 107656–107656. 2 indexed citations
6.
7.
Poizeau, F., Sandrine Kerbrat, André Happe, et al.. (2020). Patients with Metastatic Melanoma Receiving Anticancer Drugs: Changes in Overall Survival, 2010–2017. Journal of Investigative Dermatology. 141(4). 830–839.e3. 8 indexed citations
8.
Scailteux, Lucie‐Marie, Boris Campillo‐Gimenez, Sandrine Kerbrat, et al.. (2019). Performance of abiraterone and enzalutamide in metastatic castration-resistant prostate cancer men: A head to head comparison based on a 2014-2017 French population-based study. European Urology Supplements. 18(1). e1219–e1219. 2 indexed citations
9.
Scailteux, Lucie‐Marie, C. Droitcourt, Frédéric Balusson, et al.. (2018). French administrative health care database (SNDS): The value of its enrichment. Therapies. 74(2). 215–223. 64 indexed citations
10.
Poizeau, F., Elisabeth Nowak, Sandrine Kerbrat, et al.. (2018). L’ustékinumab déclenche-t-il des accidents cardiovasculaires ? (SNDS-SNIIRAM 2010–2016). Annales de Dermatologie et de Vénéréologie. 145(12). S94–S94. 1 indexed citations
11.
Scailteux, Lucie‐Marie, S. Vincendeau, Frédéric Balusson, et al.. (2017). Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists—a nationwide population-based cohort study based on 2010–2013 French Health Insurance data. European Journal of Cancer. 77. 99–108. 44 indexed citations
12.
Drézen, Erwan, Thomas Guyet, & André Happe. (2017). From medico‐administrative databases analysis to care trajectories analytics: an example with the French SNDS. Fundamental and Clinical Pharmacology. 32(1). 78–80. 5 indexed citations
13.
Happe, André & Erwan Drézen. (2017). A visual approach of care pathways from the French nationwide SNDS database – from population to individual records: the ePEPS toolbox. Fundamental and Clinical Pharmacology. 32(1). 81–84. 10 indexed citations
14.
Nowak, Emmanuel, André Happe, J. Bouget, et al.. (2015). Safety of Fixed Dose of Antihypertensive Drug Combinations Compared to (Single Pill) Free-Combinations. Medicine. 94(49). e2229–e2229. 9 indexed citations
15.
Polard, Élisabeth, Elisabeth Nowak, André Happe, Arnaud Biraben, & Emmanuel Oger. (2015). Brand-name to generic substitution of antiepileptic Drugs (AED) does not lead to seizure-related hospitalization: a Population-based case-crossover study. Clinical Therapeutics. 37(8). e114–e114. 1 indexed citations
16.
Polard, Élisabeth, et al.. (2015). Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study. Pharmacoepidemiology and Drug Safety. 24(11). 1161–1169. 16 indexed citations
17.
Schad, Friedemann, Jan Axtner, André Happe, et al.. (2012). Health Service Research in Integrative Oncology: Viscum Album Use and Non-Pharmacotherapeutic Interventions in Lung Cancer Patients. Annals of Oncology. 23. ix466–ix466. 1 indexed citations
18.
Cuggia, Marc, Nicolas Garcelon, Boris Campillo‐Gimenez, et al.. (2011). Roogle: An Information Retrieval Engine for Clinical Data Warehouse. Studies in health technology and informatics. 169. 584–8. 30 indexed citations
19.
Happe, André, Bruno Pouliquen, Anita Burgun, Marc Cuggia, & P. Le Beux. (2003). Automatic concept extraction from spoken medical reports. International Journal of Medical Informatics. 70(2-3). 255–263. 26 indexed citations
20.
Duff, Franck Le, et al.. (2001). Sharing medical data for patient path analysis with data mining method.. PubMed. 84(Pt 2). 1364–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Levent Doğanay Breakdown of academic impact, for papers by Rui Yang Breakdown of academic impact, for papers by Libing Ma Breakdown of academic impact, for papers by Ulrich Buergi Breakdown of academic impact, for papers by Li‐Wen Huang Breakdown of academic impact, for papers by Zhu Ming Breakdown of academic impact, for papers by Xiaoming Su
Rankless by CCL
2026